Biggest News Aggregation in the World
📰 Patrick Holt News

Page 7 - Patrick Holt News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Patrick Holt. Real-time updates on events, politics, business and more.

Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying - Indaptus Therapeutics (NASDAQ:INDP), Amarin Corp (NASDAQ:AMRN)

The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Robertg Spignesi Jr Glenr Anderson Paul Manning Patrick Holt Dow Jones Taysha Gene Therapies Inc

Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy - Amarin Corp (NASDAQ:AMRN)

– Dutch Ministry of Health Approves VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce the Risk of Cardiovascular Events in Patients with Established Cardiovascular Disease – – Italy's AIFA Pricing
New Jersey United States The Netherlands Patrick Holt Mark Marmur Prevenzione Italia

Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy

– Dutch Ministry of Health Approves VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce the Risk of Cardiovascular Events in Patients with Established Cardiovascular Disease – – Italy’s AIFA Pricing & Reimbursement Committee (CPR) Issues Negative Decision on VAZKEPA; Follows Positive Scientific Assessment by the Italian Scientific Technical Committee (CTS) – DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Amarin Co...
United States New Jersey The Netherlands Mark Marmur Patrick Holt Prevenzione Italia
Source: yahoo.com

Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)

-- VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within NHSScotland, as secondary prevention in adult statin-treated patients at high cardiovascular risk1 -- -- VAZKEPA® already commercially available in England, Wales, and Northern Ireland where NICE recommended its reimbursement and use across the National Health Service (NHS) in July 2022 -- -- Amarin now working with Health Boards across Scotland to secure formulary inclusion and ...
United Kingdom United States Glasgow City Northern Ireland New Jersey Mark Marmur
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science